AJP - Regu AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 262: R761-R765, 1992;
0363-6119/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerper, L. E.
Right arrow Articles by Clarkson, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerper, L. E.
Right arrow Articles by Clarkson, T. W.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 262, Issue 5 761-R765, Copyright © 1992 by American Physiological Society

ARTICLES

Methylmercury transport across the blood-brain barrier by an amino acid carrier

L. E. Kerper, N. Ballatori and T. W. Clarkson
Department of Biophysics, University of Rochester School of Medicine, New York 14642.

The mechanism by which methylmercury (MeHg) crosses the blood-brain barrier was examined in the rat. Previous studies demonstrated that intravenous injection of L-cysteine with MeHg accelerates MeHg uptake into brain. Since the complex of MeHg with L-cysteine is structurally similar to L-methionine, a substrate for the L (leucine-preferring) amino acid transport system, this carrier may be involved in MeHg uptake. To examine this hypothesis, the rapid carotid infusion technique was used in the anesthetized rat. The concentration dependence of 203Hg uptake into brain after injection of Me203Hg-L-cysteine complex was nonlinear, exhibiting characteristics of saturable transport (apparent Michaelis constant 0.39 mM, vmax 33 nmol.min-1.g-1). A slower, nonsaturable uptake was seen after MeHg-L-cysteine uptake was inhibited by methionine and the amino acid analogue 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH), an L system substrate, but not by alpha-methylaminoisobutyric acid, an alanine-preferring system substrate. Furthermore, L-[14C]methionine transport was inhibited by MeHg-L-cysteine but not by MeHgCl. There was a significant amount of uptake of 203Hg when injected as Me203Hg-glutathione, and this was inhibited by L-methionine and BCH but not D-methionine. S-ethylglutathione also inhibited 203Hg uptake after administration as Me203Hg-glutathione but had no effect on Me203Hg-L-cysteine uptake. These results suggest that MeHg may enter the brain as a cysteine complex via the L system and that plasma MeHg-glutathione serves as a source of MeHg-cysteine.


This article has been cited by other articles:


Home page
 PediatricsHome page
K. B. Nelson and M. L. Bauman
Thimerosal and Autism?
Pediatrics, March 1, 2003; 111(3): 674 - 679.
[Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. C. Foulkes
Transport of Toxic Heavy Metals Across Cell Membranes
Experimental Biology and Medicine, March 1, 2000; 223(3): 234 - 240.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
V. T. CANNON, D. W. BARFUSS, and R. K. ZALUPS
Molecular Homology and the Luminal Transport of Hg2+ in the Renal Proximal Tubule
J. Am. Soc. Nephrol., March 1, 2000; 11(3): 394 - 402.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. K. Zalups
Molecular Interactions with Mercury in the Kidney
Pharmacol. Rev., March 1, 2000; 52(1): 113 - 144.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online